Stay updated on Oncolytics Biotech Press Releases

Sign up to get notified when there's something new on the Oncolytics Biotech Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Oncolytics Biotech Press Releases page

  1. Check
    yesterday
    Change Detected
    Summary
    Stock information on the Investor Overview page was updated to reflect a current price of $0.87 with a change of -$0.013 and -1.48% on June 2, 2026. New items were added announcing Steve Glover's appointment to the Board and John McAdory's promotion to COO (June 1–2, 2026) and positive preclinical findings for pelareorep in combination with RAS-targeted approaches, while older items about durable responses in second-line RAS-Mutant MSS colorectal cancer and FDA alignment on a planned anal cancer study were removed.
    Difference
    3%
    Check dated 2026-06-05T11:45:52.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Stock quote values were updated to $0.94, $0.035, and 3.89% with the date May 22, 2026. A new ASCO 2026 press release headline was added, while the prior April 6, 2026 data and FDA meeting headline were removed.
    Difference
    3%
    Check dated 2026-05-29T06:53:17.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The NASD: ONCY stock quote on the investor overview page has been updated, showing a current price of $0.79 with a daily change of -$0.03 and -3.66%, replacing the prior values of $0.87, $0.002, and 0.23%.
    Difference
    0.9%
    Check dated 2026-05-22T08:48:03.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The stock quote values were updated from $0.90 (-$0.02, -2.17%) to $0.87 (+$0.002, +0.23%), reflecting the latest intraday movement. This update shows the current price and the day's small positive delta relative to the previous close.
    Difference
    0.9%
    Check dated 2026-05-15T02:22:01.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The Investor Overview page now reflects updated market data with a stock quote of $0.90, a -$0.02 change, and a -2.17% change dated May 4, 2026. It also adds the press release 'Oncolytics Biotech® Reports Durable Responses in Second-Line RAS-Mutant MSS Colorectal Cancer' and removes the older stock figure ($0.93) and the domicile-change press release.
    Difference
    3%
    Check dated 2026-05-07T23:20:57.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The Investor Overview page now shows updated NASD: ONCY pricing at $0.93 with a $0.061 move and 7.00% as of April 27, 2026, along with the new press release headline 'Oncolytics Aligns with FDA on Planned Pivotal Anal Cancer Study,' replacing the previous data and headline.
    Difference
    3%
    Check dated 2026-04-30T17:42:06.000Z thumbnail image

Stay in the know with updates to Oncolytics Biotech Press Releases

Enter your email address, and we'll notify you when there's something new on the Oncolytics Biotech Press Releases page.